Announcement PDF DELTA LITHIUM LIMITED ACN 107 244 039 NOTICE OF ANNUAL GENERAL MEETING The annual general meeting of Delta Lithium Limited will be held at The Celtic Club, 48 Ord Street, West Perth, Western Australia 6005 at 10.00am (AWST) on Tuesday, 17 November 2026 It may not be possible for Shareholders to physically attend the Meeting. As a result, the Company encourages Shareholders who cannot attend the Meeting in person to vote by directed proxy. Proxy Forms for the Meeting should be lodged before 10.00am (AWST) on Sunday, 15 November 2026. Shareholders can also submit, and are encouraged to submit, any questions in advance of the Meeting by emailing the questions to the Company Secretary at p.gilford@deltalithium.com.au by no later than 4.00pm (AWST) on Tuesday, 10 November 2026. If the above arrangements with respect to the Meeting change, Shareholders will be updated via the ASX Market Announcements Platform and on the Company's website at https://deltalithium.com.au/. This Notice should be read in its entirety. If Shareholders are in doubt as to how they should vote, they should seek advice from their accountant, solicitor or other professional adviser prior to voting. Should you wish to discuss any matter, please do not hesitate to contact the Company by telephone on +61 8 6109 0104. P a g e | 1 DELTA LITHIUM LIMITED ACN 107 244 039 NOTICE OF ANNUAL GENERAL MEETING Notice is hereby given that the annual general meeting of shareholders of Delta Lithium Limited ACN 107 244 039 (Company) will be held at The Celtic Club, 48 Ord Street, West Perth, Western Australia 6005 on Tuesday, 17 November 2026 at 10.00am (AWST) (Meeting). The Explanatory Memorandum provides additional information on matters to be considered at the Meeting. The Explanatory Memorandum and the Proxy Form form part of this Notice. We recommend Shareholders read the Explanatory Memorandum in relation to the proposed Resolutions. The Directors have determined pursuant to regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the persons eligible to vote at the Meeting are those who are registered as Shareholders on Sunday, 15 November 2026 at 4.00pm (AWST). The Company advises that a poll will be conducted for all Resolutions. Terms and abbreviations used in this Notice and the Explanatory Memorandum will, unless the context requires otherwise, have the meaning given to them in Schedule 1. AGENDA FINANCIAL STATEMENTS AND REPORTS To receive and consider the Annual Report of the Company and its controlled entities for the financial year ended 30 June 2026, which includes the declaration of the Directors, the Directors' Report, the Financial Report and the Auditor’s Report. Note: There is no requirement for Shareholders to approve these reports. Pursuant to the Corporations Act, Shareholders will be given a reasonable opportunity at the Meeting to ask questions about, or make comments in relation to, each of the aforementioned reports during consideration of these items. 1 RESOLUTION 1 – ADOPTION OF REMUNERATION REPORT To consider and, if thought fit, to pass, with or without amendment, the following resolution as a non- binding ordinary resolution: “That, pursuant to and in accordance with section 250R(2) of the Corporations Act and for all other purposes, Shareholders approve the adoption of the Remuneration Report as contained in the Company’s Annual Report for the financial year ended 30 June 2026 on the terms and conditions in the Explanatory Memorandum.” Note: The vote on this Resolution is advisory only and does not bind the Directors or the Company. The Directors will consider the outcome of the vote and comments made by Shareholders on the Remuneration Report at the Meeting when reviewing the Company’s remuneration policies. Voting Prohibition A vote on this Resolution must not be cast (in any capacity) by or on behalf of either of the following persons: (a) a member of the Key Management Personnel, details of whose remuneration are included in the Remuneration Report; or (b) a Closely Related Party of such a member. However, a person (the voter) described above may cast a vote on this Resolution as a proxy if the vote is not cast on behalf of a person described above and either: (a) the voter is appointed as a proxy by writing that specifies the way the proxy is to vote on this Resolution; or P a g e | 2 (b) the voter is the Chair and the appointment of the Chair as proxy: (i) does not specify the way the proxy is to vote on this Resolution; and (ii) expressly authorises the Chair to exercise the proxy even though this Resolution is connected directly or indirectly with the remuneration of a member of the Key Management Personnel. 2 RESOLUTION 2 – RE-ELECTION OF DIRECTOR – MR NADER EL SAYED To consider and, if thought fit, to pass with or without amendment, the following resolution as an ordinary resolution: “That, pursuant to and in accordance with Listing Rule 14.5, clause 14.2 of the Constitution and for all other purposes, Mr Nader El Sayed, a Director, retires, and being eligible, is re-elected as a Director on the terms and conditions in the Explanatory Memorandum.” 3 RESOLUTION 3 – APPROVAL OF 10% PLACEMENT FACILITY To consider and, if thought fit, to pass with or without amendment, the following resolution as a special resolution: “That, pursuant to and in accordance with Listing Rule 7.1A and for all other purposes, Shareholders approve the issue of Equity Securities up to 10% of the issued capital of the Company (at the time of issue) calculated in accordance with the formula prescribed in Listing Rule 7.1A.2 and otherwise on the terms and conditions set out in the Explanatory Memorandum.” Voting Exclusion The Company will disregard any votes cast in favour of this Resolution by or on behalf of a person who is expected to participate in the proposed issue, who will obtain a material benefit as a result of the proposed issue of securities (except a benefit solely in the capacity of a holder of ordinary securities in the entity) or an associate of that person (or those persons). However, this does not apply to a vote cast in favour of this Resolution by: (a) a person as proxy or attorney for a person who is entitled to vote on this Resolution, in accordance with directions given to the proxy or attorney to vote on this Resolution in that way; or (b) the Chair as proxy or attorney for a person who is entitled to vote on this Resolution, in accordance with a direction given to the Chair to vote on this Resolution as the Chair decides; or (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met: (i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on this Resolution; and (ii) the holder votes on this Resolution in accordance with directions given by the beneficiary to the holder to vote in that way. Note: As at the date of this Notice, it is not known who may participate in any Equity Securities issued under Resolution 3 and the Company has not approached any Shareholder or identified a class of existing Shareholders to participate in any issue of Equity Securities under the 10% Placement Facility. Accordingly, no Shareholders are excluded from voting on Resolution 3. P a g e | 3 By order of the Board Peter Gilford Company Secretary Dated: 16 October 2026 DELTA LITHIUM LIMITED ACN 107 244 039 EXPLANATORY MEMORANDUM 1 INTRODUCTION This Explanatory Memorandum has been prepared for the information of Shareholders in connection with the business to be conducted at the Meeting to be held at The Celtic Club, 48 Ord Street, West Perth, Western Australia 6005 on Tuesday, 17 November 2026 at 10.00am (AWST). This Explanatory Memorandum forms part of the Notice which should be read in its entirety. This Explanatory Memorandum contains the terms and conditions on which the Resolutions will be voted. This Explanatory Memorandum does not take into account the individual investment objectives, financial situation and needs of individual Shareholders or any other person. Accordingly, it should not be relied on solely in determining how to vote on the Resolutions and Shareholders should seek their own financial or legal advice. Certain statements in this Explanatory Memorandum relate to the future. These statements reflect views only as of the date of this Explanatory Memorandum. While the Company believes that the expectations reflected in the forward-looking statements are reasonable, neither the Company nor any other person gives any representation, assurance or guarantee that the occurrence of an event expressed or implied in any forward-looking statements in this Explanatory Memorandum will actually occur. This Explanatory Memorandum includes the following information to assist Shareholders in deciding how to vote on the Resolutions: Section 2 Action to be taken by Shareholders Section 3 Financial Statements and Reports Section 4 Resolution 1 – Adoption of Remuneration Report Section 5 Resolution 2 – Re-election of Director (Mr Nader El Sayed) Section 6 Resolution 3 – Approval of 10% Placement Facility Schedule 1 Definitions A Proxy Form is enclosed with the Notice. 2 ACTION TO BE TAKEN BY SHAREHOLDERS Shareholders should read the Notice including this Explanatory Memorandum carefully before deciding how to vote on the Resolutions. The Company advises that a poll will be conducted for all Resolutions. 2.1 Proxies A Proxy Form is enclosed with the Notice. This is to be used by Shareholders if they wish to appoint a representative (a 'proxy') to vote in their place. All Shareholders are invited and encouraged to attend the Meeting or, if they are unable to attend in person, to sign and return the Proxy Form to the Company in accordance with the instructions thereon. Returning the Proxy Form will not preclude a Shareholder from attending and voting at the Meeting in person. Please note that: (a) a member of the Company entitled to attend and vote at the Meeting is entitled to appoint a proxy; (b) a proxy need not be a member of the Company; and (c) a member of the Company entitled to cast two or more votes may appoint two proxies and may specify the proportion or number of votes each proxy is appointed to exercise. Where the proportion or number is not specified, each proxy may exercise half of the votes. If a Shareholder appoints a body corporate as its proxy and the body corporate wishes to appoint an individual as its representative, the body corporate should provide that person with a certificate or letter executed in accordance with the Corporations Act authorising him or her to act as that body corporate’s representative. The authority may be sent to the Company or its share registry in advance of the Meeting or handed in at the Meeting when registering as a corporate representative. Proxy Forms must be received by the Company no later than 10.00am (AWST) on Sunday, 15 November 2026, being at least 48 hours before the Meeting. Proxy Forms received later than this time will be invalid. The enclosed Proxy Form provides further details on appointing proxies and lodging Proxy Forms. 2.2 Attendance at the Meeting If it becomes necessary or appropriate to make alternative arrangements to those detailed in this Notice, Shareholders will be updated via the ASX announcements platform and on the Company’s website at https://deltalithium.com.au/. 3 FINANCIAL STATEMENTS AND REPORTS In accordance with the Corporations Act, the business of the Meeting will include receipt and consideration of the Annual Report of the Company for the financial year ended 30 June 2026 together with the declaration of the Directors, the Directors’ Report, the Financial Report and the Auditor’s Report. There is no requirement for Shareholders to approve the Annual Report. At the Meeting, Shareholders will be offered the opportunity to: (a) discuss the Annual Report, which is available online at https://deltalithium.com.au/financial- reports/; (b) ask questions about, or make comments on, the management of the Company; (c) ask questions about, or make comments on, the Remuneration Report; and (d) ask the auditor questions about: (i) the conduct of the audit; (ii) the preparation and content of the Auditor's Report; (iii) accounting policies adopted by the Company in relation to the preparation of the financial statements; and (iv) the independence of the auditor in relation to the conduct of the audit. In addition to taking questions at the Meeting, written questions to the Chair about the management of the Company, or to the Company's auditor about: (a) the content of the Auditor's Report; or (b) the conduct of the audit, may be submitted no later than five business days before the Meeting (being no later than 4.00pm (AWST) on Tuesday, 10 November 2026) to the Company Secretary at the Company's registered office or by email to p.gilford@deltalithium.com.au. Please note that if you have elected to continue to receive a hard copy of the Annual Report, it will be mailed to you no later than 28 days before the Meeting. However, if you did not elect to continue to receive a hard copy of the Annual Report and now (or at some time in the future) wish to receive a hard copy of the Annual Report, please contact the Company, who will arrange to mail you a hard copy. The Company will not provide a hard copy of the Company’s Annual Report to Shareholders unless specifically requested to do so. The Company’s Annual Report is available on its website at https://deltalithium.com.au/financial-reports/. 4 RESOLUTION 1 – ADOPTION OF REMUNERATION REPORT 4.1 Background The Corporations Act requires that at a listed company’s annual general meeting, a resolution that the remuneration report be adopted must be put to the shareholders. However, such a resolution is advisory only and does not bind the Company or the Directors. The Remuneration Report sets out the Company’s remuneration arrangements for the Directors and other Key Management Personnel of the Company. The Remuneration Report is part of the Directors’ Report contained in the Annual Report. The Board is committed to an appropriately structured remuneration framework, underpinned by guiding remuneration principles, focused on driving a performance culture over the short, medium and long term to deliver satisfactory returns to Shareholders. The Remuneration Report: (a) sets out the components of executive and non-executive Directors’ remuneration, including any associated performance conditions (if any); (b) defines the Company's remuneration objectives and structure for fixed and variable short and long term remuneration frameworks; and (c) confirms the remuneration of the Directors and other members of Key Management Personnel for the year ended 30 June 2026. In accordance with section 250R(3) of the Corporations Act, Resolution 1 is advisory only and does not bind the Directors or the Company. If Resolution 1 is not passed, the Directors will not be required to alter any of the arrangements in the Remuneration Report. Resolution 1 is a non-binding ordinary resolution. The Chair intends to exercise all available undirected proxies in favour of Resolution 1. If the Chair is appointed as your proxy and you have not specified the way the Chair is to vote on Resolution 1, by returning the Proxy Form, you are considered to have provided the Chair with an express authorisation for the Chair to vote the proxy in accordance with the Chair's intention, even though Resolution 1 is connected directly or indirectly with the remuneration of members of the Key Management Personnel. The Chair must allow a reasonable opportunity for Shareholders to ask questions about or make comments on the Remuneration Report at the Meeting. 4.2 Voting consequences The Corporations Act provides that a company is required to put to its shareholders a resolution proposing the calling of another meeting of shareholders to consider the appointment of directors of the company (Spill Resolution) if, at consecutive annual general meetings, at least 25% of the votes cast on a remuneration report resolution are voted against adoption of the remuneration report and at the first of those annual general meetings a Spill Resolution was not put to vote. If required, the Spill Resolution must be put to vote at the second of those annual general meetings. If more than 50% of votes cast are in favour of the Spill Resolution, the company must convene a shareholder meeting (Spill Meeting) within 90 days of the second annual general meeting. All of the directors of the company who were in office when the directors' report (as included in the company’s annual financial report for the most recent financial year) was approved, other than the managing director of the company, will cease to hold office immediately before the end of the Spill Meeting but may stand for re-election at the Spill Meeting. Following the Spill Meeting those persons whose election or re-election as directors of the company is approved will be the directors of the company. 4.3 Previous voting results At the Company’s previous annual general meeting the votes cast against the remuneration report considered at that annual general meeting were less than 25%. Accordingly, a Spill Resolution is not relevant for this Meeting. 4.4 Board recommendation The Board abstains, in the interests of good corporate governance, from making a recommendation in relation to Resolution 1. 5 RESOLUTION 2 – RE-ELECTION OF DIRECTOR – MR NADER EL SAYED 5.1 General In accordance with Listing Rule 14.5, an entity which has directors must hold an election of directors at each annual general meeting. Clause 14.2 of the Constitution requires that at the Company’s annual general meeting in every year, one-third of the Directors for the time being, or, if their number is not a multiple of three, then the number nearest one-third (rounded upwards to the nearest whole number), shall retire from office, provided always that no Director (except a managing director) shall hold office for a period in excess of three years, or until the third annual general meeting following his or her appointment, whichever is the longer, without submitting himself or herself for re-election. Directors to retire at an annual general meeting are those who have been longest in office since their last election, but, as between persons who became Directors on the same day, those to retire shall (unless they otherwise agree among themselves) be determined by drawing lots. A retiring Director is eligible for re-election. Resolution 2 provides that, pursuant to and in accordance with Listing Rule 14.5 and clause 14.2 of the Constitution (and for all other purposes), Mr Nader El Sayed, who has served as a Director since 1 March 2021 and was last elected at the Company's annual general meeting held on 29 November 2023, retires and being eligible, is re-elected as a Director. If Resolution 2 is passed, Mr El Sayed will be re-elected and will continue to act as a Director, subject to retirement or certain other events, for the next three years. If Resolution 2 is not passed, Mr El Sayed will, as applicable, not be re-elected and will cease to act as a Director. Resolution 2 is an ordinary resolution. The Chair intends to exercise all available undirected proxies in favour of Resolution 2. 5.2 Qualifications and other material directorships - Mr Nader El Sayed Mr Nader El Sayed is currently the Managing Director of Multiplant Holdings, a mining and civil services business in Western Australia. His previous roles include a senior management position with KPMG providing assurance, capital markets and other advisory services to key Australian and international resource companies. Mr El Sayed brings a wealth of capital markets, risk management, corporate governance and strategic experience to the Board. Mr El Sayed holds a Bachelor of Commerce (Banking & Finance), Masters (Accounting) and has completed the Australian Institute of Chartered Accountants program. Mr El Sayed is also a Non-Executive Director of Gwardar Resources Ltd (ASX:GRS), an ASX Listed exploration company. 5.3 Independence Nader El Sayed has no interests, position or relationship that might influence, or reasonably be perceived to influence, in a material respect his capacity to bring an independent judgement to bear on issues before the Board and to act in the best interest of the Company as a whole rather than in the interests of an individual security holder or other party. If re-elected, the Board considers Nader El Sayed will be an independent Director. 5.4 Board recommendation The Board (excluding Mr El Sayed) recommends that Shareholders vote in favour of Resolution 2. 6 RESOLUTION 3 – APPROVAL OF 10% PLACEMENT FACILITY 6.1 General Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of Equity Securities that a listed company can issue without the approval of its shareholders over any 12-month period to 15% of the fully paid ordinary securities it had on issue at the start of that period (15% Placement Capacity). Listing Rule 7.1A enables an Eligible Entity (term defined below) to issue Equity Securities up to 10% of its issued share capital through placements over a 12-month period after the annual general meeting (10% Placement Facility). The 10% Placement Facility is in addition to the Company's 15% Placement Capacity under Listing Rule 7.1. An ‘Eligible Entity’ means an entity which is not included in the S&P/ASX 300 Index and has a market capitalisation of $300,000,000 or less. As at the date of this Notice, the Company is an ‘Eligible Entity’ for these purposes as it is not included in the S&P/ASX 300 Index and has a current market capitalisation of $126 million (based on the number of Shares on issue and the closing price of Shares on the ASX on 7 October 2026). Pursuant to Resolution 3, the Company is seeking Shareholder approval to issue Equity Securities under the 10% Placement Facility. The number of Equity Securities to be issued under the 10% Placement Facility will be determined in accordance with the formula prescribed in Listing Rule 7.1A.2 (refer to Section 6.2(c)). If Resolution 3 is passed, the Company will be able to issue Equity Securities under Listing Rule 7.1A up to 10% of its issued share capital over a 12-month period after the annual general meeting, in addition to the Company’s 15% Placement Capacity under Listing Rule 7.1. If Resolution 3 is not passed, the Company will not be able to access the 10% Placement Facility to issue Equity Securities without Shareholder approval provided for in Listing Rule 7.1A and will remain subject to the 15% Placement Capacity under Listing Rule 7.1. Resolution 3 is a special resolution and therefore requires approval of 75% of the votes cast by Shareholders present and eligible to vote (in person, by proxy, by attorney or, in the case of a corporate Shareholder, by a corporate representative). The Chair intends to exercise all available proxies in favour of Resolution 3. 6.2 Listing Rule 7.1A (a) Shareholder approval The ability to issue Equity Securities under the 10% Placement Facility is subject to Shareholder approval by way of a special resolution at an annual general meeting. (b) Equity Securities Any Equity Securities issued under the 10% Placement Facility must be in the same class as an existing quoted class of Equity Securities of the Company. The Company, as at the date of the Notice, has on issue one quoted class of Equity Securities, being Shares. (c) Formula for calculating 10% Placement Facility Listing Rule 7.1A.2 provides that Eligible Entities which have obtained Shareholder approval at an annual general meeting may issue or agree to issue, during the 12-month period after the date of the annual general meeting, a number of Equity Securities calculated in accordance with the following formula: (A x D) – E A is the number of Shares on issue at the commencement of the Relevant Period: (A) plus the number of Shares issued in the relevant period under an exception in Listing Rule 7.2 other than exception 9, 16 or 17; (B) plus the number of Shares issued in the relevant period on the conversion of convertible securities within Listing Rule 7.2 exception 9 where: (I) the convertible securities were issued or agreed to be issued before the commencement of the relevant period; or (II) the issue of, or agreement to issue, the convertible securities was approved, or taken under the Listing Rules to have been approved under Listing Rule 7.1 or 7.4; (C) plus the number of Shares issued in the relevant period under an agreement to issue securities within Listing Rule 7.2 exception 16 where: (I) the agreement was entered into before the commencement of the relevant period; or (II) the agreement was approved, or taken under these rules to have been approved, under Listing Rule 7.1 or 7.4; (D) plus the number of any other Shares issued in the relevant period with approval under Listing Rule 7.1 or 7.4; (E) plus the number of partly paid ordinary shares that became fully paid in the relevant period; and (F) less the number of Shares cancelled in the relevant period. Note that A has the same meaning in Listing Rule 7.1 when calculating an entity's 15% Placement Capacity. D is 10% E is the number of Equity Securities issued or agreed to be issued under Listing Rule 7.1A.2 in the Relevant Period where the issue or agreement has not been subsequently approved by Shareholders under Listing Rule 7.4. (d) Listing Rule 7.1 and Listing Rule 7.1A The ability of an entity to issue Equity Securities under Listing Rule 7.1A is in addition to the entity's 15% Placement Capacity under Listing Rule 7.1. At the date of the Notice, the Company has on issue 719,762,857 Shares and therefore has a capacity to issue: (i) 107,964,428 Equity Securities under Listing Rule 7.1; and (ii) subject to Shareholder approval being sought under Resolution 3, 71,976,286 Equity Securities under Listing Rule 7.1A. The actual number of Equity Securities that the Company will have capacity to issue under Listing Rule 7.1A will be calculated at the date of issue of the Equity Securities in accordance with the formula prescribed in Listing Rule 7.1A.2 (refer to Section 6.2(c)). (e) Minimum Issue Price The issue price of Equity Securities issued under Listing Rule 7.1A must be not less than 75% of the VWAP of Equity Securities in the same class calculated over the 15 Trading Days on which trades in that class were recorded immediately before: (i) the date on which the price at which the Equity Securities are to be issued is agreed; or (ii) if the Equity Securities are not issued within 10 Trading Days of the date in Section 6.2(e)(i) above, the date on which the Equity Securities are issued. (f) 10% Placement Period Shareholder approval of the 10% Placement Facility under Listing Rule 7.1A is valid from the date of the annual general meeting at which the approval is obtained and expires on the earlier to occur of: (i) the date that is 12 months after the date of the annual general meeting at which the approval is obtained; (ii) the time and date of the entity’s next annual general meeting; or (iii) the date and time of Shareholder approval of a transaction under Listing Rules 11.1.2 (a significant change to the nature or scale of activities) or 11.2 (disposal of main undertaking), (the 10% Placement Period). 6.3 Effect of Resolution The effect of Resolution 3 will be to allow the Directors to issue the Equity Securities under Listing Rule 7.1A during the 10% Placement Period without using the Company's 15% Placement Capacity under Listing Rule 7.1. 6.4 Specific information required by Listing Rule 7.3A Pursuant to and in accordance with Listing Rule 7.3A, the information below is provided in relation to Resolution 3: (a) Period for which the 7.1A Mandate is valid The 10% Placement Facility under Listing Rule 7.1A is valid from the date of the Meeting and will expire on the first to occur of the following: (i) the date that is 12 months after the date of this Meeting; (ii) the time and date of the Company’s next annual general meeting; and (iii) the time and date of approval by Shareholders of any transaction under Listing Rule 11.1.2 (a significant change in the nature or scale of activities) or Listing Rule 11.2 (disposal of the main undertaking). (b) Minimum price Any Equity Securities issued under the 10% Placement Facility must be in an existing quoted class of Equity Securities and be issued for cash consideration at a minimum price of 75% of the VWAP of Equity Securities in that class, calculated over the 15 Trading Days on which trades in that class were recorded immediately before: (i) the date on which the price at which the Equity Securities are to be issued is agreed by the entity and the recipient of the Equity Securities; or (ii) if the Equity Securities are not issued within 10 Trading Days of the date in Section 6.4(b)(i), the date on which the Equity Securities are issued. (c) Use of funds raised under the 10% Placement Facility The Company intends to use funds raised from issues of Equity Securities under the 10% Placement Facility for: (i) the acquisition of new resources, assets, and investments (including expenses associated with such an acquisition); (ii) continued exploration expenditure on the Company’s current assets and/or projects (funds would then be used for project, feasibility studies and ongoing project administration); (iii) the development of the Company’s current business; and (iv) general working capital. (d) Risk of Economic and Voting Dilution Any issue of Equity Securities under the 10% Placement Facility will dilute the interests of Shareholders who do not receive any Shares under the issue.